BioNTech SE Other Operating Income or Expenses 2019-2024 | BNTX
BioNTech SE other operating income or expenses for the twelve months ending December 31, 2024 were $-0.726B, a 256.8% increase year-over-year.
- BioNTech SE annual other operating income or expenses for 2024 were $-0.726B, a 256.8% increase from 2023.
- BioNTech SE annual other operating income or expenses for 2023 were $-0.203B, a 147.3% decline from 2022.
- BioNTech SE annual other operating income or expenses for 2022 were $0.43B, a 27.86% decline from 2021.
